|
1
|
Upregulation of the 5-lipoxygenase pathway in human aortic valves correlates with severity of stenosis and leads to leukotriene-induced effects on valvular myofibroblasts.
|
Circulation
|
2011
|
1.78
|
|
2
|
Nationwide cohort study of the leukotriene receptor antagonist montelukast and incident or recurrent cardiovascular disease.
|
J Allergy Clin Immunol
|
2012
|
1.20
|
|
3
|
Differential inflammatory activity across human abdominal aortic aneurysms reveals neutrophil-derived leukotriene B4 as a major chemotactic factor released from the intraluminal thrombus.
|
FASEB J
|
2009
|
1.12
|
|
4
|
Leukotriene receptor antagonism and the prevention of extracellular matrix degradation during atherosclerosis and in-stent stenosis.
|
Arterioscler Thromb Vasc Biol
|
2009
|
0.96
|
|
5
|
Leukotrienes and atherosclerosis.
|
Curr Drug Targets
|
2010
|
0.95
|
|
6
|
Eicosanoids and their drugs in cardiovascular diseases: focus on atherosclerosis and stroke.
|
Med Res Rev
|
2012
|
0.94
|
|
7
|
Increased urinary leukotriene E4 excretion in obstructive sleep apnea: effects of obesity and hypoxia.
|
J Allergy Clin Immunol
|
2009
|
0.93
|
|
8
|
The role of matrix metalloproteinases in atherothrombosis.
|
Curr Atheroscler Rep
|
2011
|
0.90
|
|
9
|
Inflammatory mediators in saliva associated with arterial stiffness and subclinical atherosclerosis.
|
J Hypertens
|
2013
|
0.88
|
|
10
|
Leukotriene B4 pathway activation and atherosclerosis in obstructive sleep apnea.
|
J Lipid Res
|
2012
|
0.87
|
|
11
|
Valvular osteoclasts in calcification and aortic valve stenosis severity.
|
Int J Cardiol
|
2013
|
0.85
|
|
12
|
NOD2-mediated innate immune signaling regulates the eicosanoids in atherosclerosis.
|
Arterioscler Thromb Vasc Biol
|
2013
|
0.84
|
|
13
|
Leukotrienes as modifiers of preclinical atherosclerosis?
|
ScientificWorldJournal
|
2012
|
0.84
|
|
14
|
Thromboxane synthase expression and thromboxane A2 production in the atherosclerotic lesion.
|
J Mol Med (Berl)
|
2010
|
0.84
|
|
15
|
Effects of the dual TP receptor antagonist and thromboxane synthase inhibitor EV-077 on human endothelial and vascular smooth muscle cells.
|
Biochem Biophys Res Commun
|
2013
|
0.84
|
|
16
|
Intermittent hypoxia-activated cyclooxygenase pathway: role in atherosclerosis.
|
Eur Respir J
|
2012
|
0.82
|
|
17
|
Inhibition of nitric-oxide synthase enhances antigen-induced contractions and increases release of cysteinyl-leukotrienes in guinea pig lung parenchyma: nitric oxide as a protective factor.
|
J Pharmacol Exp Ther
|
2005
|
0.81
|
|
18
|
Urinary leukotriene E4 is associated with renal function but not with endothelial function in type 2 diabetes.
|
Dis Markers
|
2013
|
0.80
|
|
19
|
Cysteinyl leukotriene signaling through perinuclear CysLT(1) receptors on vascular smooth muscle cells transduces nuclear calcium signaling and alterations of gene expression.
|
J Mol Med (Berl)
|
2012
|
0.79
|
|
20
|
Pharmacological evidence for a novel cysteinyl-leukotriene receptor subtype in human pulmonary artery smooth muscle.
|
Br J Pharmacol
|
2002
|
0.79
|
|
21
|
Increased transcript level of poly(ADP-ribose) polymerase (PARP-1) in human tricuspid compared with bicuspid aortic valves correlates with the stenosis severity.
|
Biochem Biophys Res Commun
|
2012
|
0.79
|
|
22
|
Altered reactivity to norepinephrine through COX-2 induction by vascular injury in hypercholesterolemic rabbits.
|
Am J Physiol Heart Circ Physiol
|
2009
|
0.79
|
|
23
|
The contractile action of leukotriene B4 in the guinea-pig lung involves a vascular component.
|
Br J Pharmacol
|
2004
|
0.79
|
|
24
|
Prosthesis-patient mismatch after transcatheter aortic valve implantation: impact of 2D-transthoracic echocardiography versus 3D-transesophageal echocardiography.
|
Int J Cardiovasc Imaging
|
2014
|
0.78
|
|
25
|
Specific mediator inhibition by the NO donors SNP and NCX 2057 in the peripheral lung: implications for allergen-induced bronchoconstriction.
|
Respir Res
|
2009
|
0.77
|
|
26
|
Cardiovascular Events Associated With Use of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Population-Based Cohort Study.
|
Ann Intern Med
|
2016
|
0.76
|
|
27
|
Epigenetic regulation of 5-lipoxygenase in the phenotypic plasticity of valvular interstitial cells associated with aortic valve stenosis.
|
FEBS Lett
|
2012
|
0.76
|
|
28
|
The leukotriene receptor antagonist montelukast and aortic stenosis.
|
Br J Clin Pharmacol
|
2013
|
0.75
|
|
29
|
Receptor preferences of cysteinyl-leukotrienes in the guinea pig lung parenchyma.
|
Eur J Pharmacol
|
2002
|
0.75
|
|
30
|
Leukotrienes as a molecular link between obstructive sleep apnoea and atherosclerosis.
|
Cardiovasc Res
|
2013
|
0.75
|
|
31
|
Gamma-glutamyltransferase, leukotrienes, and cardiovascular risk.
|
Eur Heart J
|
2006
|
0.75
|
|
32
|
Cysteinyl-leukotrienes in cerebrovascular disease: angels and demons?
|
Arterioscler Thromb Vasc Biol
|
2008
|
0.75
|
|
33
|
Transesophageal echocardiography measurements of aortic annulus diameter using biplane mode in patients undergoing transcatheter aortic valve implantation.
|
Cardiovasc Ultrasound
|
2013
|
0.75
|
|
34
|
Disease duration of rheumatoid arthritis is a predictor of vascular stiffness: a cross-sectional study in patients without known cardiovascular comorbidities: A STROBE-compliant article.
|
Medicine (Baltimore)
|
2017
|
0.75
|
|
35
|
3D TEE with stereovision for guidance of the transcatheter mitral valve repair.
|
JACC Cardiovasc Imaging
|
2012
|
0.75
|
|
36
|
Hemodynamic outcomes of transcatheter aortic valve implantation with the CoreValve system: an early assessment.
|
Clin Physiol Funct Imaging
|
2014
|
0.75
|